Puyang Zhongyi Kangwa Yinhuang Granules, offered by Henan Nomi Pharmaceutical Co., Ltd. under the Renhe brand and supplied as 4 g x 12 sachets, are described as clearing heat, detoxifying, and soothing the throat, with sore throat, acute pharyngitis, and tonsillitis among the indications. The product belongs to a category that regulators find comparatively straightforward, because unlike a whole-herb powder it is built from two standardised extracts. That distinction shapes both its quality control and its path into foreign markets.
Yinhuang preparations are composed of a Lonicera japonica (honeysuckle) extract and a Scutellaria baicalensis extract. Because the ingredients are extracts rather than powdered plant material, manufacturers can specify marker compounds, with chlorogenic acid commonly used for the honeysuckle extract and baicalin for the Scutellaria extract. Analytical methods such as high-performance liquid chromatography allow a laboratory to measure these markers and confirm that each batch falls within a defined range. For a buyer, this means the quality discussion can be concrete: you can ask for measured marker content, not just a statement that the product is genuine.
Within China, Yinhuang products are established as over-the-counter Chinese patent medicines manufactured under a drug production licence and GMP conditions, and each batch carries an approval number and expiry date. When the same product crosses a border, the classification may change. Some countries assess it as a herbal medicinal product requiring a registration dossier, while others regulate it as a dietary supplement or traditional herbal remedy with a lighter notification route. Exporters therefore need a document set that typically includes a certificate of analysis, a GMP certificate, the manufacturing licence, the product licence, and often a free-sale certificate, and they must confirm how the destination market will classify the goods before shipment.
Beyond marker content, sensible checks include moisture, microbial limits, and heavy-metal testing, plus confirmation that the granule dissolves cleanly. Storage instructions should be followed, usually sealed and protected from moisture, and buyers should verify the sachet weight and count against the specification, since naming conventions for this family can vary between suppliers.
Q: What makes Yinhuang easier to quality-control than many herbal formulas? A: Its two ingredients are standardised extracts, so laboratories can measure defined markers such as chlorogenic acid and baicalin instead of assessing a complex whole-herb powder.
Q: What paperwork is normally needed to export Yinhuang Granules? A: A batch certificate of analysis, GMP certificate, manufacturing licence, product licence, and frequently a free-sale certificate, plus confirmation of how the destination market classifies the product.
Q: Why might the same product be a medicine in one market and a supplement in another? A: Because national rules differ. Some regulators treat a standardised herbal preparation as a medicinal product, while others place it in a supplement or traditional-remedy category with different requirements.
Puyang Zhongyi Kangwa Yinhuang Granules, offered by Henan Nomi Pharmaceutical Co., Ltd. under the Renhe brand and supplied as 4 g x 12 sachets, are described as clearing heat, detoxifying, and soothing the throat, with sore throat, acute pharyngitis, and tonsillitis among the indications. The product belongs to a category that regulators find comparatively straightforward, because unlike a whole-herb powder it is built from two standardised extracts. That distinction shapes both its quality control and its path into foreign markets.
Yinhuang preparations are composed of a Lonicera japonica (honeysuckle) extract and a Scutellaria baicalensis extract. Because the ingredients are extracts rather than powdered plant material, manufacturers can specify marker compounds, with chlorogenic acid commonly used for the honeysuckle extract and baicalin for the Scutellaria extract. Analytical methods such as high-performance liquid chromatography allow a laboratory to measure these markers and confirm that each batch falls within a defined range. For a buyer, this means the quality discussion can be concrete: you can ask for measured marker content, not just a statement that the product is genuine.
Within China, Yinhuang products are established as over-the-counter Chinese patent medicines manufactured under a drug production licence and GMP conditions, and each batch carries an approval number and expiry date. When the same product crosses a border, the classification may change. Some countries assess it as a herbal medicinal product requiring a registration dossier, while others regulate it as a dietary supplement or traditional herbal remedy with a lighter notification route. Exporters therefore need a document set that typically includes a certificate of analysis, a GMP certificate, the manufacturing licence, the product licence, and often a free-sale certificate, and they must confirm how the destination market will classify the goods before shipment.
Beyond marker content, sensible checks include moisture, microbial limits, and heavy-metal testing, plus confirmation that the granule dissolves cleanly. Storage instructions should be followed, usually sealed and protected from moisture, and buyers should verify the sachet weight and count against the specification, since naming conventions for this family can vary between suppliers.
Q: What makes Yinhuang easier to quality-control than many herbal formulas? A: Its two ingredients are standardised extracts, so laboratories can measure defined markers such as chlorogenic acid and baicalin instead of assessing a complex whole-herb powder.
Q: What paperwork is normally needed to export Yinhuang Granules? A: A batch certificate of analysis, GMP certificate, manufacturing licence, product licence, and frequently a free-sale certificate, plus confirmation of how the destination market classifies the product.
Q: Why might the same product be a medicine in one market and a supplement in another? A: Because national rules differ. Some regulators treat a standardised herbal preparation as a medicinal product, while others place it in a supplement or traditional-remedy category with different requirements.